Home / E-Marketing & E-Business News / I-MED Pharma Launches New Tear Osmolarity Device for Dry Eye Disease Diagnosis

I-MED Pharma Launches New Tear Osmolarity Device for Dry Eye Disease Diagnosis

I-MED Pharma Launches New Tear Osmolarity Device for Dry Eye Disease Diagnosis

I-MED Pharma, Inc. announces commercial the launch of the i-Pen, its new tear osmolarity device, for the diagnosis of Dry Eye Disease (DED).

Online PR News – 06-May-2016I-MED Pharma, Inc., a Canadian eye care company, announced today the global launch of its new medical device, the i-Pen, intended to compete in and to expand the dry eye disease (DED) diagnostic market.

The i-Pen is a hand-held device designed for an easy, quick and accurate measurement of tear osmolarity derived from ocular tissues. Daniel Hofmann, Vice-President of I-MED Pharma, commented, “The i-Pen represents a new generation of truly affordable and easy to use technology to assess dry eye disease. We are excited about the opportunities the i-Pen platform provides for clinicians and for their patients by giving them an accurate and reliable quantitative measure of DED. From the start our goal was to make this important diagnostic tool easily accessible to all healthcare professionals to help them diagnose and target dry eye treatments for their patients.”

Hofmann estimates that their business model will allow clinicians to recover their capital costs with fewer than forty patients. He anticipates that the i-Pen will be submitted to FDA in 2016 and that it will not require a CLIA waiver. In response to the patent infringement lawsuit filed in Canada by TearLab Corporation (NASDAQ:TEAR), headquartered in California, in February 2016, he stated, “It is I-MED Pharma’s position that it will not comment on pending litigation except to say that we deny infringement and we will contest the validity of the TearLab patent at issue.”

About I-MED Pharma, Inc.
I-MED Pharma is a privately held Canadian company that designs, manufactures and distributes medical, surgical and veterinary eye care products. For more information, please visit www.imedpharma.com.

Quote:

“The i-Pen represents a new generation of truly affordable and easy to use technology to assess dry eye disease. We are excited about the opportunities the i-Pen platform provides for clinicians and for their patients by giving them an accurate and reliable quantitative measure of DED.”

Company Contact Information
Daniel Hofmann
http://www.imedpharma.com
(800) 463-1008
 

About Wael Kaheel

Avatar

Check Also

How to Hit 6-Figures in 6 Months Using a Simple 3-Step Process

Welcome to this week’s attraction marketing "Biz Builder" lesson.

Today I have entrepreneur and network marketing trainer, Pamela Herrmann!

In this video, Pam shows you how to hit 6-figures in 6 months using a simple, 3-step process!

Click "Read More" below to watch this week's video!

The post How to Hit 6-Figures in 6 Months Using a Simple 3-Step Process appeared first on Elite Marketing Pro.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.